FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
Skip Navigation LinksHome / News / Read News


Prospect Capital Provides $80MM for Recapitalization of Zicam

August 12, 2013, 07:31 AM
Filed Under: Pharmaceuticals

Prospect Capital Corporation has provided $80.0 million of floating-rate first-lien senior-secured loans and a senior-secured revolving credit facility for the recapitalization of Matrixx Initiatives, Inc., owner of Zicam, a leading developer and marketer of over-the-counter cold remedy products under the Zicam brand. H.I.G. Capital, L.L.C., a leading private equity firm, owns a controlling position in Matrixx.

Based in Bridgewater, NJ, Zicam is a top 12 brand in the OTC market and is the number one brand in the cold recovery and cold prevention segment.

"We selected Prospect for its responsive culture, structuring creativity, and large balance sheet," said Brian McMullen, a principal with H.I.G.

"Zicam's leading market position, nationwide distribution, and product innovation demonstrate the strength, diversity, and growth potential of the brand," said Jason Wilson, a managing director with Prospect Capital Management. "With this investment, Prospect so far in 2013 has closed one or more transactions with H.I.G.'s offices in Miami, San Francisco, Boston, and New York."

Prospect has closed more than $1.8 billion of originations to date in the 2013 calendar year. Prospect closed more than $3.0 billion of originations in the twelve months ended June 30, 2013. Prospect is a business development company that focuses on lending to and investing in private businesses.

Comments From Our Members

You must be an ABL Advisor member to post comments. Login or Join Now.